|1.||Chang, Alice Y W: 5 articles (01/2015 - 04/2005)|
|2.||Chan, Julie Y H: 4 articles (01/2015 - 04/2005)|
|3.||Chan, Samuel H H: 4 articles (01/2015 - 04/2005)|
|4.||Tsai, Ching-Yi: 2 articles (01/2015 - 03/2014)|
|5.||Chang, A Y W: 2 articles (12/2006 - 05/2005)|
|6.||Chen, Chang-Han: 1 article (01/2015)|
|7.||Li, Brian P T: 1 article (09/2013)|
|8.||Wu, Jacqueline C C: 1 article (09/2013)|
|9.||Li, Faith C H: 1 article (09/2013)|
|10.||Chuang, Yao-Chung: 1 article (01/2009)|
01/01/1975 - "These results do not agree with those of an earlier study which decrements in VI performance of pigeons and squirrel monkeys appeared at low mevinphos doses which did not produce overt somatic signs of poisoning. "
05/01/2005 - "We evaluated the functional changes in the mitochondrial respiratory chain at the rostral ventrolateral medulla (RVLM), the medullary origin of sympathetic vasomotor tone, in an experimental model of fatal organophosphate poisoning using the insecticide mevinphos (Mev). "
08/01/1983 - "Rapid death by mevinphos poisoning while under observation."
01/01/1975 - "Performance in the DRL schedule was affected only at a dose of 0.30 mg/kg. No performance deficits or overt somatic signs of poisoning were present at mevinphos doses of 0.10 mg/kg or lower. "
01/01/1975 - "Mevinphos doses of 0.20 mg/kg and above produced observable somatic signs of poisoning and also produced dose-related decrements in performance in FR and VI tasks. "
01/01/2009 - "Intravenous administration of lethal doses of mevinphos elicited an abrupt cardiac arrest, accompanied by elevated systemic arterial pressure and anoxia, augmented neuronal excitability and enhanced microvascular perfusion in RVLM. "
04/01/2005 - "Coenzyme q10 confers cardiovascular protection against acute mevinphos intoxication by ameliorating bioenergetic failure and hypoxia in the rostral ventrolateral medulla of the rat."
|3.||Hypotension (Low Blood Pressure)
01/01/2015 - "Immunoneutralization of FJL10540 in the RVLM significantly antagonized those biochemical changes, and blunted the progressive hypotension and the reduced baroreflex-mediated sympathetic vasomotor tone during mevinphos intoxication. "
01/01/2015 - "Microinjection bilaterally of mevinphos (10nmol) into the RVLM of anesthetized Sprague-Dawley rats induced a progressive hypotension that was accompanied by an increase (Phase I), followed by a decrease (Phase II) of an experimental index for baroreflex-mediated sympathetic vasomotor tone. "
03/01/2014 - "Microinjection of mevinphos (10 nmol) bilaterally into the RVLM of anesthetized Sprague-Dawley rats induced a progressive hypotension that was accompanied sequentially by an increase (Phase I) and a decrease (Phase II) of an experimental index for the baroreflex-mediated sympathetic vasomotor tone. "
09/01/2013 - "Microinjection of mevinphos (10 nmol) into the RVLM of anesthetized Sprague-Dawley rats induced progressive hypotension that was accompanied by an increase (phase I), followed by a decrease (phase II) of an experimental index of baroreflex-mediated sympathetic vasomotor tone, with a fatality rate of 35%. "
03/01/2014 - "Loss-of-function manipulations of PI3K or Akt in the RVLM significantly antagonized the reduced baroreflex-mediated sympathetic vasomotor tone and hypotension during Phase II mevinphos intoxication, and blunted the increase in NF-κB/NOS II/peroxynitrite signaling. "
|1.||HI 6 (H16)
|4.||Obidoxime Chloride (Obidoxime)
|6.||coenzyme Q10 (CoQ10)
|7.||Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
|8.||Peroxynitrous Acid (Peroxynitrite)